发明名称 |
NOVEL VACCINE DEVELOPMENT |
摘要 |
The invention relates to a novel antigen that is capable of stimulating the T-cell lymphocyte surface receptor CD40. The adjuvant is a ligand adapted for this purpose. The invention also relates to a novel vaccine incorporating the aforementioned adjuvant and also ideally an antigen that is either a T-cell dependent antigen or a T-cell independent antigen.
|
申请公布号 |
CA2207246(A1) |
申请公布日期 |
1998.12.06 |
申请号 |
CA19972207246 |
申请日期 |
1997.06.06 |
申请人 |
THE UNIVERSITY OF SHEFFIELD |
发明人 |
HEATH, ANDREW WILLIAM |
分类号 |
A61K39/385;A61K39/39;C07K14/705;(IPC1-7):C12N15/62;A61K39/395;C12N5/10;C12N15/13 |
主分类号 |
A61K39/385 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|